Save time and get answers to complex questions with AI chat
What are the most memorable drug brands in oral factor b inhibitors? in united statesAbbvie humira patent cliff navigation success?Sun pharma bortezomib?When is tenofovir alafenamide patent expiring?Drug patent watch trametinib?
See the DrugPatentWatch profile for Toujeo
Short answer: there isn’t an approved biosimilar to Toujeo (insulin glargine U-300) yet. Biosimilars exist for insulin glargine U-100 (Lantus), not specifically for the U-300 formulation. Biosimilars for insulin glargine (Lantus) you may see: - Basaglar (insulin glargine) — a widely available biosimilar to Lantus - Semglee (insulin glargine) — another biosimilar to Lantus - Rezvoglar (insulin glargine) — a biosimilar to Lantus Notes: - Toujeo is a different formulation (U-300) with a distinct PK/PD profile from U-100 insulins, so a U-100 biosimilar is not the same as a Toujeo biosimilar. - Swapping between insulins should only be done under medical supervision, with dose adjustments as needed. If you’re asking about a specific country (US vs EU) or want tips on cost/availability, tell me and I can tailor the info.
Other Questions About Toujeo :